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Abstract
Ameloblastoma is a true neoplasm of odontogenic epithelial origin. It is the second most common odontogenic
neoplasm, and only odontoma outnumbers it in reported frequency of occurrence. Its incidence, combined with its
clinical behavior, makes ameloblastoma the most significant odontogenic neoplasm. Unicystic ameloblastoma (UA)
refers to those cystic lesions that show clinical, radiographic, or gross features of a mandibular cyst, but on histolo-
gic examination show a typical ameloblastomatous epithelium lining part of the cyst cavity, with or without lumi-
nal and/or mural tumor growth. It accounts for 5-15% of all intraosseous ameloblastomas. We report a case of
unicystic ameloblastoma in a 30-year-old female, and review the literature.
Introduction
Many benign lesions cause mandibular swellings, and
these can be divided into those of odontogenic and nono-
dontogenic origin. Lesions include ameloblastoma, radi-
cular cyst, dentigerous cyst, keratocystic odontogenic
tumour, central giant cell granuloma, fibro-osseous
lesions and osteomas [1]. The most common tumour of
odontogenic origin is ameloblastoma, which develops
from epithelial cellular elements and dental tissues in
their various phases of development. It is a slow-growing,
persistent, and locally aggressive neoplasm of epithelial
origin. Its peak incidence is in the 3rd to 4th decades of
life and has an equal sex distribution. It is often asso-
ciated with an unerupted third molar [2]. It may be
detected during the course of routine radiography.
The vast majority of ameloblastomas arise in the
mandible, and the majority of these are found in the
angle and ramus region. There are three forms of ame-
loblastomas, namely multicystic, peripheral, and unicys-
tic tumors [3]. Multicystic ameloblastoma is the most
common variety and represents 86% of cases. Peripheral
tumors are odontogenic tumors, with the histological
characteristics of intraosseous ameloblastoma that occur
solely in the soft tissues covering the tooth-bearing
parts of the jaws. Unicystic tumors include those that
have been variously referred to as mural ameloblasto-
mas, luminal ameloblastomas, and ameloblastomas
arising in dentigerous cysts [4]. The goal of treatment
ameloblastoma is to achieve complete excision and
appropriate reconstruction. We present a case of a large
unicystic mandibular ameloblastoma in a 30 year old
female.
Case Report
A 30 year old lady presented with a slowly growing
swelling on the right side of the face since one year (Fig-
ure 1). There was no associated pain, difficulty in open-
ing the mouth, chewing or articulating. On physical
examination, there was a hard non-tender mass, mea-
suring 8 cm by 5 cm arising from the right side of the
mandible, involving the ramus, angle and body upto the
right lower 1
st premolar tooth. The oral mucosa was
normal. No neck nodes were palpable. Systemic exami-
nation was normal. An orthopantomogram (OPG) was
done, which showed large cystic lesion in the right side
of mandible (Figure 2). CT scan showed that the cystic
lesion was confined to the mandible, with a thinned out
cortex (Figure 3). The patient was taken up for surgery
under general anaesthesia. A segmental mandibulectomy
was done via a lip split incision (Figures 4, 5), and pri-
mary closure achieved. The resected specimen had his-
topathologic features consistent with unilocular
ameloblastoma (Figure 6).
Discussion
Unilocular ameloblastoma (UA) is a rare type of amelo-
blastoma, accounting for about 6% of ameloblastomas. It
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of the cases occurring in the second decade of life.
More than 90% are located in the mandible [5-7].
Between 50 and 80% of cases are associated with tooth
impaction, the mandibular third molar being most often
involved. The ‘dentigerous’ type occurs 8 years earlier
on average than the ‘non-dentigerous’ variant. Patients
most commonly present with swelling and facial asym-
metry, pain being an occasional presenting symptom.
Mucosal ulceration is rare, but may be caused by
continued growth of the tumor. Small lesions are some-
times discovered more on routine radiographic screen-
ing examinations or as a result of local effects (like
tooth mobility, occlusal alterations and failure of erup-
tion of teeth) produced by the tumor [8]. Histologically,
the minimum criterion for diagnosing a lesion as UA is
the demonstration of a single cystic sac lined by odonto-
genic (ameloblastomatous) epithelium often seen only in
focal areas. UA should be differentiated from odonto-
genic cysts because the former has a higher rate of
Figure 1 Swelling right side of face.
Figure 2 OPG showing cystic lesion.
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study of 57 cases of unicystic ameloblastoma, Acker-
mann [3] classified this entity into the following three
histologic groups:
Group I: Luminal UA (tumor confined to the lumi-
nal surface of the cyst)
Group II: Intraluminal/plexiform UA (nodular prolif-
eration into the lumen without infiltration of tumor
cells into the connective tissue wall), and
Group III: Mural UA (invasive islands of ameloblas-
tomatous epithelium in the connective tissue wall
not involving the entire epithelium).
Another histologic subgrouping by Philipsen and
Reichart [4] has also been described:
Subgroup 1: Luminal UA
Subgroup 1.2: Luminal and intraluminal
Subgroup 1.2.3: Luminal, intraluminal and intramural
Subgroup 1.3: Luminal and intramural
Figure 3 CT scan showing lesion in right hemimandible.
Figure 4 Lip split approach - mandibotomy.
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treated conservatively (careful enucleation), whereas
subgroups 1.2.3 and 1.3 showing intramural growths
require treated radical resection, as for a solid or multi-
cystic ameloblastoma [5]. Following enucleation, vigor-
ous curettage of the bone should be avoided as it may
implant foci of ameloblastoma more deeply into bone.
Chemical cauterization with Carnoy’ss o l u t i o ni sa l s o
advocated for subgroups 1 and 1.2. Subgroups 1.2.3 and
1.3 have a high risk for recurrence, requiring more
aggressive surgical procedures. This is because the cystic
wall in these cases has islands of ameloblastoma tumor
cells and there may be penetration into the surrounding
cancellous bone [10-12]. Late recurrence following treat-
ment is commonly seen, the average interval for recur-
rence being 7 years. Recurrence is also related to
Figure 5 Resection complete.
Figure 6 Resected specimen.
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fibrous wall having a rate of 35.7%, but others only 6.7%
[12]. Recurrence rates are also related to the type of
initial treatment. Lau et al [13] reported recurrence
rates of 3.6% for resection, 30.5% for enucleation alone,
16% for enucleation followed by Carnoy’s solution appli-
cation, and 18% by marsupialization followed by enu-
cleation (where the lesion reduced in size).
Conflict of interests
The authors declare that they have no competing
interests.
Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Acknowledgements
The authors are grateful to Dr. Arun Shet for review of the manuscript.
Authors’ contributions
RSR participated in the surgical excision and drafted the manuscript
SM conceived the study and participated in drafting manuscript and co-
ordination
THU obtained consent and photographs and participated in the literature
search
SP participated in surgical excision and in drafting manuscript
SK performed the surgical excision and participated in literature search
All authors read and approved the final manuscript.
Received: 1 November 2009
Accepted: 14 January 2010 Published: 14 January 2010
References
1. Kahairi A, Ahmad RL, Wan Islah L, Norra H: Management of large
mandibular ameloblastoma - a case report and literature reviews.
Archives of Orofacial Sciences 2008, 3(2):52-55.
2. Gerzenshtein J, Zhang F, Caplan J, Anand V, Lineaweaver W: Immediate
mandibular reconstruction with microsurgical fibula flap transfer
following wide resection for ameloblastoma. J Craniofac Surg 2006,
17(1):178-182.
3. Philipsen HP, Reichart PA: Classification of odontogenic tumors and allied
lesions. Odontogenic tumors and allied lesions Quintessence Pub. Co. Ltd
2004, 21-3.
4. Chana , Jagdeep S, Yang-Ming Chang, Wei , Fu-Chan , Shen , Yu-Fen ,
Chan Chiu-Po, Lin Hsiu-Na, Tsai Chi-Ying, Jeng Seng-Feng: Segmental
mandibulectomy and immediate free fibula osteoseptocutaneous flap
reconstruction with endosteal implants: An ideal treatment method for
mandibular ameloblastoma. Plast Reconstr Surg 2004, 113(1):80-87.
5. Philipsen HP, Reichart PA: Unicystic ameloblastoma. Odontogenic tumors
and allied lesions London: Quintessence Pub. Co. Ltd 2004, 77-86.
6. Pizer ME, Page DG, Svirsky JA: Thirteen-year follow-up of large recurrent
unicystic ameloblastoma of the mandible in a 15-year-old boy. J Oral
Maxillofac Surg 2002, 60:211-5.
7. Navarro CM, Principi SM, Massucato EM, Sposto MR: Maxillary unicystic
ameloblastoma. Dentomaxillofac Radiol 2004, 33:60-2.
8. Roos RE, Raubenheimer EJ, van Heerden WF: Clinico-pathological study of
30 unicystic ameloblastomas. J Dent Assoc S Afr 1994, 49:559-62.
9. Konouchi H, Asaumi J, Yanagi Y, Hisatomi M, Kawai N, Matsuzaki H, Kishi K:
Usefulness of contrast enhanced-MRI in the diagnosis of unicystic
ameloblastoma. Oral Oncol 2006, 42:481-6.
10. Li TJ, Kitano M, Arimura K, Sugihara K: Recurrence of unicystic
ameloblastoma: A case report and review of the literature. Arch Pathol
Lab Med 1998, 122:371-4.
11. Li TJ, Browne RM, Matthews JB: Expression of proliferating cell nuclear
antigen (PCNA) and Ki-67 in unicystic ameloblastoma. Histopathology
1995, 26:219-28.
1 2 . L iT ,W uY ,Y uS ,Y uG :Clinicopathological features of unicystic
ameloblastoma with special reference to its recurrence. Zhonghua Kou
Qiang Yi Xue Za Zhi 2002, 37:210-2.
13. Lau SL, Samman N: Recurrence related to treatment modalities of
unicystic ameloblastoma: A systematic review. Int J Oral Maxillofac Surg
2006, 35:681-90.
doi:10.1186/1758-3284-2-1
Cite this article as: Ramesh et al.: Unicystic ameloblastoma of the
mandible - an unusual case report and review of literature. Head & Neck
Oncology 2010 2:1.
Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Ramesh et al. Head Neck Oncology 2010, 2:1
http://www.headandneckoncology.org/content/2/1/1
Page 5 of 5